Vanguard Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.8M | Buy |
2,157,430
+76,967
| +4% | +$849K | ﹤0.01% | 2479 |
|
2025
Q1 | $18.6M | Buy |
2,080,463
+69,919
| +3% | +$624K | ﹤0.01% | 2536 |
|
2024
Q4 | $18.9M | Sell |
2,010,544
-41,145
| -2% | -$387K | ﹤0.01% | 2616 |
|
2024
Q3 | $16.5M | Buy |
2,051,689
+49,510
| +2% | +$399K | ﹤0.01% | 2688 |
|
2024
Q2 | $17M | Sell |
2,002,179
-683,674
| -25% | -$5.8M | ﹤0.01% | 2651 |
|
2024
Q1 | $24.1M | Sell |
2,685,853
-803,409
| -23% | -$7.21M | ﹤0.01% | 2507 |
|
2023
Q4 | $39.2M | Sell |
3,489,262
-350,067
| -9% | -$3.93M | ﹤0.01% | 2287 |
|
2023
Q3 | $33.1M | Sell |
3,839,329
-379,627
| -9% | -$3.28M | ﹤0.01% | 2329 |
|
2023
Q2 | $43.7M | Sell |
4,218,956
-1,407,770
| -25% | -$14.6M | ﹤0.01% | 2244 |
|
2023
Q1 | $61M | Buy |
5,626,726
+67,887
| +1% | +$737K | ﹤0.01% | 2081 |
|
2022
Q4 | $62.4M | Sell |
5,558,839
-447,294
| -7% | -$5.02M | ﹤0.01% | 2061 |
|
2022
Q3 | $60.9M | Sell |
6,006,133
-538,673
| -8% | -$5.46M | ﹤0.01% | 2086 |
|
2022
Q2 | $59.3M | Sell |
6,544,806
-403,141
| -6% | -$3.65M | ﹤0.01% | 2110 |
|
2022
Q1 | $66.4M | Buy |
6,947,947
+648,124
| +10% | +$6.2M | ﹤0.01% | 2159 |
|
2021
Q4 | $69.6M | Buy |
6,299,823
+443,268
| +8% | +$4.9M | ﹤0.01% | 2173 |
|
2021
Q3 | $43.3M | Buy |
5,856,555
+577,586
| +11% | +$4.27M | ﹤0.01% | 2436 |
|
2021
Q2 | $76.7M | Buy |
5,278,969
+763,854
| +17% | +$11.1M | ﹤0.01% | 2137 |
|
2021
Q1 | $92.2M | Sell |
4,515,115
-139,194
| -3% | -$2.84M | ﹤0.01% | 1990 |
|
2020
Q4 | $82.7M | Buy |
4,654,309
+79,431
| +2% | +$1.41M | ﹤0.01% | 1928 |
|
2020
Q3 | $67.6M | Sell |
4,574,878
-123,496
| -3% | -$1.83M | ﹤0.01% | 1867 |
|
2020
Q2 | $98.6M | Buy |
4,698,374
+265,318
| +6% | +$5.57M | ﹤0.01% | 1684 |
|
2020
Q1 | $102M | Buy |
4,433,056
+429,454
| +11% | +$9.92M | ﹤0.01% | 1515 |
|
2019
Q4 | $104M | Sell |
4,003,602
-5,431
| -0.1% | -$141K | ﹤0.01% | 1732 |
|
2019
Q3 | $78.1M | Buy |
4,009,033
+76,246
| +2% | +$1.49M | ﹤0.01% | 1854 |
|
2019
Q2 | $64.2M | Buy |
3,932,787
+54,562
| +1% | +$891K | ﹤0.01% | 1973 |
|
2019
Q1 | $87.9M | Sell |
3,878,225
-101,835
| -3% | -$2.31M | ﹤0.01% | 1814 |
|
2018
Q4 | $102M | Buy |
3,980,060
+308,030
| +8% | +$7.88M | ﹤0.01% | 1670 |
|
2018
Q3 | $120M | Buy |
3,672,030
+126,135
| +4% | +$4.12M | ﹤0.01% | 1713 |
|
2018
Q2 | $80.4M | Buy |
3,545,895
+108,949
| +3% | +$2.47M | ﹤0.01% | 1881 |
|
2018
Q1 | $83.3M | Buy |
3,436,946
+38,614
| +1% | +$936K | ﹤0.01% | 1810 |
|
2017
Q4 | $94.8M | Buy |
3,398,332
+105,277
| +3% | +$2.94M | ﹤0.01% | 1750 |
|
2017
Q3 | $113M | Buy |
3,293,055
+95,778
| +3% | +$3.28M | 0.01% | 1636 |
|
2017
Q2 | $127M | Buy |
3,197,277
+116,981
| +4% | +$4.66M | 0.01% | 1533 |
|
2017
Q1 | $113M | Buy |
3,080,296
+125,223
| +4% | +$4.61M | 0.01% | 1589 |
|
2016
Q4 | $94.2M | Buy |
2,955,073
+279,926
| +10% | +$8.92M | 0.01% | 1653 |
|
2016
Q3 | $96.9M | Buy |
2,675,147
+223,581
| +9% | +$8.1M | 0.01% | 1578 |
|
2016
Q2 | $55.6M | Buy |
2,451,566
+497,350
| +25% | +$11.3M | ﹤0.01% | 1854 |
|
2016
Q1 | $36.7M | Buy |
1,954,216
+156,695
| +9% | +$2.95M | ﹤0.01% | 2006 |
|
2015
Q4 | $29.5M | Buy |
1,797,521
+134,114
| +8% | +$2.2M | ﹤0.01% | 2136 |
|
2015
Q3 | $18.3M | Buy |
1,663,407
+59,985
| +4% | +$659K | ﹤0.01% | 2323 |
|
2015
Q2 | $20.9M | Buy |
1,603,422
+23,555
| +1% | +$307K | ﹤0.01% | 2336 |
|
2015
Q1 | $27.4M | Buy |
1,579,867
+93,842
| +6% | +$1.63M | ﹤0.01% | 2195 |
|
2014
Q4 | $22.2M | Buy |
1,486,025
+18,779
| +1% | +$280K | ﹤0.01% | 2197 |
|
2014
Q3 | $33.8M | Buy |
1,467,246
+96,664
| +7% | +$2.23M | ﹤0.01% | 1986 |
|
2014
Q2 | $43.7M | Buy |
+1,370,582
| New | +$43.7M | ﹤0.01% | 1897 |
|